Adjuvant therapy has feverish results in real-world careFebrile neutropenia observed at higher than expected rate Catheter ablation tops medications in atrial fibrillation Caution eases over using antivirals for pandemic H1N1 Chemo- trastuzumab combo ups survival Dabigatran lowers deep vein clot risk Newer drug compares well with warfarin and does not require lab monitoring Intensive type 2 diabetes treatment fraught with danger Low HbA1c levels and insulin-based therapy are linked with increased mortality in British database Mystery miscarriages not helped by anticoagulation Trial debunks treatment that has become popular for unexplained fetal loss despite lack of evidence Natural products targeting diabetes vary in value While products in question seem safe, not all boast effectiveness. Negation exemptions needed for focused-practice visits, says OMA head Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Oral drugs may hold new hope for MS patients Ease of use is attractive, but questions remain over what longer-term use will show about side-effects Prescription chart toppers The top prescription drugs in Canada: a special report prepared by IMS Health First Previous 981 982 983 984 985 Next Last
